Cuna, Rosita L.
HRN: 25-09-60 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/30/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
05/30/2024
06/06/2024
IV
2.25grams
Q8hrs
Pyonephrosis
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes